Stockreport

TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy [Yahoo! Finance]

Protara Therapeutics, Inc.  (TARA) 
PDF of its ongoing mid-stage study evaluating intravesical TARA-002 for treating non-muscle invasive bladder cancer (NMIBC). TARA-002 is Protara's investigational cell the [Read more]